Background: In many types of cancers zinc deficiency and overproduction of Hedgehog (Hh) ligand co-exist.
Results: Zinc binds to the active site of the Hedgehog-intein (Hint) domain and inhibits Hh ligand production both in vitro and in cell culture.
Conclusion: Zinc influences the Hh autoprocessing.
Significance: This study uncovers a novel mechanistic link between zinc and the Hh signaling pathway.
Keywords: Cancer, Hedgehog Signaling Pathway, Isothermal Titration Calorimetry (ITC), Nuclear Magnetic Resonance (NMR), Zinc, Hedgehog Autoprocessing
Abstract
Zinc is an essential trace element with wide-ranging biological functions, whereas the Hedgehog (Hh) signaling pathway plays crucial roles in both development and disease. Here we show that there is a mechanistic link between zinc and Hh signaling. The upstream activator of Hh signaling, the Hh ligand, originates from Hh autoprocessing, which converts the Hh precursor protein to the Hh ligand. In an in vitro Hh autoprocessing assay we show that zinc inhibits Hh autoprocessing with a Ki of 2 μm. We then demonstrate that zinc inhibits Hh autoprocessing in a cellular environment with experiments in primary rat astrocyte culture. Solution NMR reveals that zinc binds the active site residues of the Hh autoprocessing domain to inhibit autoprocessing, and isothermal titration calorimetry provided the thermodynamics of the binding. In normal physiology, zinc likely acts as a negative regulator of Hh autoprocessing and inhibits the generation of Hh ligand and Hh signaling. In many diseases, zinc deficiency and elevated level of Hh ligand co-exist, including prostate cancer, lung cancer, ovarian cancer, and autism. Our data suggest a causal relationship between zinc deficiency and the overproduction of Hh ligand.
Introduction
Hedgehog (Hh)3 signaling pathway regulates cell proliferation, tissue polarity, and cell differentiation during normal development (1). Abnormal signaling of this pathway has been reported in a variety of human diseases, including cancer and neurodevelopmental diseases. For example, chronic Hh pathway stimulation is observed in prostate cancer (2–4), lung cancer (5, 6), and ovarian cancer (7, 8) in a Hh ligand-dependent manner. Recently, serum levels of Hh ligand protein were found to be significantly higher in children with autism spectrum disorder (ASD) and the levels of Hh ligand were correlated with the severity of autism (9). However, the mechanisms of Hh ligand overproduction in these diseases are poorly understood.
Hh ligand is generated from a precursor protein composed of an N-terminal signaling domain (HhN) and a C-terminal autoprocessing (HhC) domain (Fig. 1A), through intein-like chemistry catalyzed by the Hint (Hedgehog/intein) domain within HhC. During Hh autoprocessing, HhC cleaves HhN from the precursor and covalently links a cholesterol molecule to the C terminus of HhN. HhN is also palmitoylated at the N terminus by the Hedgehog acyl transferase (10). The double lipidation of HhN is required for proper Hh ligand transportation and downstream signaling (11). Because zinc inhibits intein-mediated protein splicing (12) and HhC is homologous to inteins (13), we reasoned that zinc may also suppress Hh autoprocessing and the generation of Hh ligand.
Interestingly, zinc deficiency has been well documented in many diseases with elevated level of Hh ligand (14–21) both in patient serum and affected tissues. If zinc normally inhibits Hh autoprocessing, low zinc level can potentially enhance Hh autoprocessing and increase the level of Hh ligand in these diseases, contributing to their pathogenesis. However, the mechanistic link between zinc and Hh signaling has not been characterized previously. In this study we demonstrate that zinc binds directly to the active site of Hint domain and inhibits the autoprocessing of Hh precursor both in vitro and in cell culture, uncovering a novel connection between two essential pathways in many physiological and pathological processes.
EXPERIMENTAL PROCEDURES
DNA Constructs
The expression plasmid, pET22b-SHhN-DHhC, encoding HhN of human Sonic Hh fused to HhC of Drosophila melanogaster was prepared by ligating the corresponding synthetic gene fusion (Genscript) into pET22b (Novagen) using unique NdeI and HindIII sites (Fig. 1B). For pET45b His6-shortened Hh precursor, the coding sequence for D. melanogaster HhC fragment was PCR-amplified from genomic DNA, digested with KpnI and HindIII, and ligated into pET45b to generate an N-terminal His-tagged construct (see Fig. 3A). Primers sequences, with restriction sites underlined were as follows: forward, TTTCACGTGGGTACCGGTGAAAACCTGTATTTTCAGGGCTCGACGGTGCATGGCTGCTTC; reverse, TTTAAGCTTAATCGTGGCGCCAGCTCTGCGGCAGAACG.
Protein Expression and Purification
All non-labeled cells were grown at 37 °C in Escherichia coli strain BL21 (DE3) and induced with 1 mm isopropyl β-d-1-thiogalactopyranoside at an A600 of ∼0.5 and then incubated at 20 °C overnight. Cells were lysed by B-per lysis buffer (Thermo Scientific, Waltham, MA) and purified by nickel-nitrilotriacetic acid chromatography. Hint domain was cleaved from the shortened precursor with 200 mm dithiothreitol (DTT) at 25 °C overnight. Affinity chromatography was utilized again to trap the His6 tag, and uncleaved fusion protein and flow-through fractions were pooled. The pure protein was exchanged by dialysis into a buffer containing 50 mm Tris, pH 7.1, 100 mm NaCl, and concentrated by ultrafiltration with Amicon Ultra Centrifugal Filter Devices (Millipore Corp.; 10-kDa molecular weight cutoff). NMR sample preparation for Hint was described previously (22).
In Vitro Autoprocessing Assays and Zinc Treatment
Autoprocessing reactions contain ∼0.16 mg/ml SHhN-DHhC precursor in incubation buffer (50 mm Tris, 100 mm NaCl, pH 7.1) with or without cholesterol (500 μm final concentration). The reactions were incubated at 25 °C and were stopped after 1 h by adding SDS-PAGE sample buffer (without β-mercaptoethanol). The samples were separated by SDS-PAGE. N-S acyl shift reactions contained ∼0.25 mg/ml shortened Hh precursor, composed of a His tag, four HhN residues, HVHG, and Drosophila-Hint (see Fig. 3A) in incubation buffer (50 mm Tris, 100 mm NaCl, pH 7.1) with or without hydroxylamine (HA) (200 mm final concentration). The reactions were incubated at 25 °C and were stopped after 3 h by adding SDS-PAGE sample buffer (without β-mercaptoethanol). The samples were analyzed by SDS-PAGE.
For zinc inhibition assay on cholesteroylation, the Hh protein was incubated with cholesterol (500 μm final concentration) and various concentration of zinc (0.5–100 μm ZnCl2) at 25 °C for 1 h. EDTA was used to as the chelator for zinc. Hh autoprocessing was monitored by SDS-PAGE. For the zinc inhibition assay on N-S acyl shift, the shortened Hh precursor, as depicted in Fig. 3A, was incubated with 200 mm HA and various concentrations of zinc (3–75 μm ZnCl2) at 25 °C for 3 h. EDTA was used to as the chelator for zinc. Hh N-S acyl shift was monitored by SDS-PAGE.
Dose-response curves and Ki values for both cholesteroylation and N-S acyl shift were determined by fitting the data with four parameter logarithmic nonlinear regression analysis with KaleidaGraph software. The dose-response equation we used was,
Liquid Chromatography (LC)-Mass Spectrometry
Protein samples were diluted to 25 μg/ml and analyzed using an Agilent 1200-Series LC system coupled to an LTQ-Orbitrap mass spectrometer (Thermo Scientific). For Fig. 1F, the LC system was equipped with a 2.1-mm inner diameter, 100-mm HPLC column packed with 5 μm BioBasic, C18, 300 Å resin (Thermo Scientific). Elution was achieved with a gradient of 5–90% B (98% acetonitrile in 1% formic acid) in 15 min. The flow rate was 0.2 ml/min.
ITC Titrations
Isothermal titration calorimetry measurements were obtained at 25 °C with an ITC200 MicroCal MCS titration microcalorimeter. Typically, 30 or 50 portions of 5 μl of ZnCl2 solution were injected into the protein in the sample cell during each titration. The delay between injections (300 s) was sufficiently long for the thermal equilibrium before the next injection. The heat released by the interaction was measured by the instrument. Heat of dilution was obtained from a control titration of zinc into buffer alone under the same conditions. All experiments were repeated three times. Integrated heat data corrected for heats of dilution were fitted with a nonlinear least-squares minimization algorithm to a theoretical titration curve, with the Origin software package supplied by MicroCal. The ITC data are presented by showing the baseline-adjusted experimental titration (heat flow versus time) on the top and the peak-integrated concentration-normalized molar heat flow per aliquot versus the titrant-to-sample molar ratio on the bottom (Fig. 3). The solid line in the bottom plot represents the best fit of the data to the one-site equilibrium binding expression.
NMR Spectroscopy
All NMR experiments were carried out at 298 K on a Bruker 800 MHz spectrometer equipped with a cryogenic probe. Spectra were processed with nmrPipe software (23) and analyzed using Sparky (T. D. Goddard and D. G. Kneller, SPARKY 3, University of California, San Francisco, CA). The 1H chemical shifts were referenced relative to DSS (2,2-dimethyl-2-silapentanesulfonic acid), and the 15N and 13C chemical shifts were referenced indirectly. The complete backbone and aliphatic side chain assignment of Hint has been published (22). The assignment of histidines were based on the (Hβ)Cβ(CγCδ)Hδ spectrum, which connects Cβ to Hδ in the imidazole ring.
Chemical shift perturbation on backbone was monitored using 1H,15N-HSQC spectra at increasing molar ratios of zinc to Hint. To monitor the zinc binding on cysteines (Cys-1 and Cys-143), aspartic acid (Asp-46), and histidine (His-72) side chains, 13C,1H-HSQC, two dimensional HB(CB)CO, and aromatic 13C,1H-HSQC spectra were acquired separately.
Culture of Primary Astrocytes
Primary astrocyte cultures were prepared from the cerebral cortex of newborn Sprague-Dawley rats as previously described (24, 25). All animal procedures in this study strictly adhered to the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of Rensselaer Polytechnic Institute. Postnatal 1-day-old rat pups were euthanized by rapid decapitation. The cerebral cortices were separated from the meninges, hippocampi, and basal ganglia. The cortical tissue from four animals was dissociated in Opti-MEM (Invitrogen) and transferred into a solution containing a 1:1 mix of recombinant protease TrypLE and Opti-MEM (Invitrogen). Cells were separated from the tissue using three 10-min incubations with TrypLE/Opti-MEM supplemented with 1 mg/ml DNase I (Sigma). The second and third extractions were combined with Dulbecco's minimal essential medium (Invitrogen) containing 10% heat inactivated horse serum (Invitrogen) and 50 units/ml penicillin plus 50 μg/ml streptomycin (Invitrogen). Cells were pelleted using centrifugation (0.5 relative centrifugal force for 5 min), resuspended in media, and plated on poly-d-lysine-coated T75 culture flasks at a density of 200,000 cells/flask. The astrocytes were cultured until reaching confluency and used for subsequent procedures as described below. Purity of astrocyte cultures (>95% pure) was periodically verified using immunocytochemistry staining protocols with an antibody against astrocytic marker glial fibrillary acidic protein (Dako, Glostrup, Denmark). The density of confluent astrocytes was ∼1 × 105 cells/cm2, which were subsequently used for Western blot analysis.
H2O2 and Zinc Treatment in Astrocytes
Astrocytes were incubated in a serum-free medium for 3 h before exposure to H2O2. H2O2 (100 μm) (Sigma) was used to induce oxidative stress and hence enhance the Hh signaling pathway. Astrocytes then were treated by 0, 50, 100, and 150 μm ZnCl2 for 40 h, where minimal zinc toxicity was observed in Live/Dead assay (Fig. 2, C and D).
Immunoblotting
Astrocytes were lysed on ice for 40 min in lysis buffer radioimmune precipitation assay buffer supplemented with PMSF and protease inhibitors (Cell Signaling). The lysate was centrifuged for 10 min at 4 °C and 10,000 × g, and then the supernatant was collected. For the culture medium, the cellular debris was separated by centrifuge at 8000 × g for 5 min, and then the proteins were concentrated by Centricon centrifugal concentrators (10-kDa cutoff, Amicon). The samples were mixed with SDS-PAGE sample buffer and separated by SDS-PAGE followed by immunoblotting on PVDF membrane. The membranes were blocked and incubated with a 1:100 dilution of HhN antibody (N-19, Santa Cruz Biotechnology). GADPH was used as a loading control by probing the GADPH portion of the blot in parallel with the portion containing Hh.
The autoprocessing efficiency was calculated by the following equation.
where I represents the gel band intensity quantified by ImageJ, and Mr is molecular weight.
Cell Viability
Live/Dead assays were done in primary astrocyte cell culture to examine the toxicity of zinc to astrocyte cultures. Cells were incubated with 0–600 μm ZnCl2 for 40 h together with 100 μm H2O2. Then cell viability was assessed using the Live/Dead cell imaging kit (Invitrogen #R37601) according to the manufacturer's directions. Stained cells were imaged using the Thermo Scientific ArrayScan XTI HCA infinity and analyzed by the Spot Detector BioApplication.
RESULTS
Zinc Inhibits Hh Autoprocessing In Vitro
Hh autoprocessing consists of two steps (Fig. 1A). The first step is an N-S acyl shift, where Cys-1 of HhC carries out a nucleophilic attack at the carbonyl of the last residue of HhN, resulting in a thioester intermediate. Step two is cholesteroylation, where a cholesterol molecule bound to the sterol recognition region of HhC acts as a nucleophile and attacks the thioester, cleaving HhN and forming a covalent bond between the cholesterol and the C terminus of HhN. The cholesterol modification of HhN together with N-terminal palmitoylation is required for the proper secretion, transportation, and signaling of Hh ligand (26). The double-lipidated HhN binds to the membrane receptor Patched (PTCH) and activates the Hh signaling pathway (1, 27). We used a construct composed of human HhN and Drosophila HhC as the precursor (SHhN-DHhC) (Fig. 1B), which has been previously used to characterize inhibitors of Hh autoprocessing (28). The autoprocessing reaction was carried out at pH 7.1, the physiologic pH in endoplasmic reticulum where Hh autoprocessing occurs (29). In the absence of cholesterol, most precursors (HhN-HhC) remain stable, with minimal nonspecific autoprocessing (Fig. 1C). In the presence of cholesterol, significant amounts of separate HhN and HhC bands are observed, indicating precursor autoprocessing. The covalent attachment of cholesterol to HhN has been confirmed by LC/electrospray ionization-MS (Fig. 1F). With increasing concentration of zinc, more and more HhN-HhC precursor remains unprocessed, whereas less and less HhC and HhN-cholesterol is generated, demonstrating the inhibitory effect of zinc on Hh autoprocessing. Quantitation of the gel bands by ImageJ (30) and curve-fitting yields a Ki of 2.3 ± 0.2 μm (Fig. 1D). As expected, this inhibitory effect by zinc is reversed by EDTA, a chelating agent for divalent metal (Fig. 1E). We also observed that zinc can inhibit Hint mediated N-S acyl shift with about Ki of 14 μm (Fig. 1, G, H, and I), indicating zinc binding to Hint plays a major role in inhibiting cholesteroylation of the full precursor.
Zinc Inhibits Hh Autoprocessing in Cell Culture
To test if zinc can inhibit Hh autoprocessing in cellular environment, we used rat primary astrocytes. Astrocytes are the most abundant glial cells in the brain (31), producing Hh ligands crucial for brain development and adult neurogenesis (31–33), whereas zinc is an important signaling molecule in the nervous system (34). The Hh precursor and HhN were detected in cell lysate and in the culture medium by Western blot, respectively. Immunoblotting for GAPDH was used as a control. We found that the Hh precursors are stably expressed, but there is no observable autoprocessing (Fig. 2A) in primary astrocyte culture. In agreement with Xia et al. (31), incubation with 100 μm H2O2 results in the secretion of HhN into the medium, whereas Hh precursor is much weaker in cell lysate (Fig. 2A), indicating the autoprocessing of Hh precursor under oxidative stress. In the presence of H2O2, with increasing concentrations of zinc up to 150 μm, increasing amounts of precursor remained unprocessed, whereas decreasing the amount of HhN was released into cell culture medium (Fig. 2A), demonstrating the concentration-dependent inhibitory effect of zinc on Hh autoprocessing in astrocytes (Fig. 2B). Therefore, an increase in environmental concentration of zinc can inhibit Hh autoprocessing in cells.
To examine the zinc toxicity, we carried out Live/Dead assays on astrocyte cultures under 0–600 μm ZnCl2 treatment. When zinc concentrations were 150 μm or smaller, cell viabilities were largely unchanged. Zinc concentrations of 200 μm and above caused substantial cell death, which is consistent with previous reports (Fig. 2, C and D) (35, 36).
Thermodynamics of Zinc-Hint Binding
This has been determined with ITC (Fig. 3B). Because zinc most likely binds to the Hint domain of Hh, the ITC is carried out with the Drosophila Hint domain at pH 7.1 at 298 K. Fitting of the isotherm in Fig. 3B resulted in the binding stoichiometry (n) of 1.06 ± 0.02 and Kd of 11 ± 2 μm from three repeated measurements. The values of the ΔH (−5.2 ± 0.2 kcal mol−1) and TΔS (1.5 ± 0.2 kcal mol−1) indicate zinc binding to Hint is both enthalpically and entropically favorable, with ΔH being the main driving factor.
Zinc Binds to Active Site Residues in Hint
We mapped the zinc binding sites in Hint domain with 1H,15N-HSQC spectra of Hint (Fig. 4, A and B), as Hint contains the key catalytic residues for Hh autoprocessing (13). The complete backbone and aliphatic side chain assignment of Hint has been published (22). The NMR signals of many amides decreased with the zinc titration (Fig. 4, A and B), such as Phe-2, Thr-3, Asp-46, Asn-54, Phe-55, Thr-69, His-72, Phe-88, Val-124, Ala-126, and Ala-141, due to chemical exchange broadening. The peaks with strongest reduction in peak intensity are likely at or close to the zinc coordination sites. When mapped onto the three-dimensional structure of Hint (13), all the residues with the largest signal reductions were close to three conserved catalytic residues Cys-1, Asp-46, and His-72 (Fig. 4C). Cysteine, aspartate, and histidine residues are the most common sites for zinc coordination in proteins (37). To further confirm the coordination role of these three residues, we also conducted zinc titration with 13C,1H-HSQC. Because Cys-1 is the first residue at the N terminus of Hint and has a very fast exchange rate with the solvent, the Cys-1 amide is not detectable with 1H,15N-HSQC. In 13C,1H-HSQC, we observed strong NMR signals for Cys-1 side chain (Fig. 5A), which disappeared upon zinc binding (Fig. 5A). Similar signal reductions upon zinc binding were also observed for Asp-46 and His-72 side chains (Fig. 5, B and C). In all experiments, the NMR signals affected by zinc reappeared upon the addition of EDTA (Fig. 5). These results establish that the Cys-1, Asp-46, and His-72 are likely zinc coordination sites in Hint. Because these three residues play a key role in Hh autoprocessing (13), when zinc binds to these three residues, the active site geometry and mobility will be perturbed, compromising their catalytic efficiency.
DISCUSSION
Zinc is an essential trace element, acting as a co-factor for >300 enzymes that regulate a variety of cellular processes and signaling pathways (38). Zinc is also a signaling molecule and can modulate synaptic activity (39). The imbalance of zinc homeostasis has been established in many pathological conditions (14–21), including many types of cancer and autism. However, the mechanistic role of zinc deficiency in these diseases remains poorly understood.
Based on our data, we propose that there is a mechanistic link between zinc deficiency and Hh-ligand-dependent activation of the Hh signaling pathway in three types of cancers, prostate cancer, lung cancer, and ovarian cancer. Lung cancer is the leading cause of death. Prostate cancer is the second most common cancer in man, whereas ovarian cancer is the leading cause of death from gynecologic malignancy. In these three cancers Hh ligand is overproduced resulting in abnormal activation of Hh signaling pathway (2–8), whereas zinc deficiency has also been clearly established (14–21). The zinc level in the human prostate is the highest among any soft tissue in the healthy body. Decrease in zinc is observed early in the course of prostate cancer development, and the trend continues toward castration-resistant disease (40). Several studies showed the depression of zinc concentration in the cancerous human lung tissues, especially in the small cell lung cancer, the most malignant form in lung cancer (17, 19, 41). For ovarian cancer, serum zinc decreased in patients subsequently diagnosed with ovarian cancer, whereas in tumor tissue, the concentration of zinc also decreased (20, 21). However, the precise pathogenic role of zinc deficiency is not known in these cancers. Our in vitro and cell culture experiments (Figs. 1 and 2) demonstrated that zinc inhibits Hh autoprocessing. These data suggest that low zinc in tissues can enhance Hh autoprocessing and generate more Hh ligand; thus, zinc deficiency can be a novel mechanism of Hh ligand overproduction in these cancers. Hh pathway inhibitors targeting the downstream receptor Smoothened (SMO) have recently generated much excitement as a novel type of therapy for cancer (11). However, drug resistance to SMO inhibitors is already emerging (42), and SMO inhibitors are not effective against tumors driven by overproduction of Hh ligand (11). Our data suggest targeting the upstream autoprocessing of Hh may be an important alternative for inhibiting Hh pathway in diseases, particularly those driven by high levels of Hh ligand. Our biophysical studies of zinc-Hh interaction will contribute to rational design of inhibitors of Hh autoprocessing.
ASD, with an astounding prevalence of ∼2% (43), is characterized by abnormal social interaction, communication, and stereotyped behaviors in affected children. The etiology of ASD is poorly understood, but both oxidative stress (44) and low zinc status have been reproducibly associated with ASD (16, 45). In astrocyte culture, Hh autoprocessing is promoted by H2O2 and low zinc level (Fig. 2A), offering a plausible mechanistic explanation for the recent observation of increased serum level of sonic Hh ligand in ASD (9). The resulting higher level of secreted Hh ligand may lead to the abnormal activation of Hh signaling pathway in both neurons and glial cells in the developing brain. A clinical feature of ASD, macrocephaly, also implicates Hh activation (46–48). Hh plays an important role in the early expansion of the developing brain and in regulating the cerebral cortical size (49, 50). In contrast, the opposite clinical feature, microcephaly, is observed in holoprosencephaly (51), which can be caused by mutations in the Hh autoprocessing domain (HhC) that reduce Hh ligand production (51–54). The abnormal activation of Hh pathway, even transiently by fluctuations in zinc level, may cause brain overgrowth, disrupting the proper development of neuronal network for language and social interactions. We, therefore, hypothesize that in ASD low zinc status promotes Hh autoprocessing and the generation of higher level of Hh ligand. Coupled with oxidative and/or genetic defects in other Hh signaling components, low zinc status may lead to abnormal activation of Hh signaling pathway during brain development, contributing to the complex etiology of ASD.
There is an apparent discrepancy between nanomolar levels of concentration of free zinc in cytosol and endoplasmic reticulum (55–58) where Hh autoprocessing occurs, and the μm Ki of zinc inhibition of Hh autoprocessing measured in vitro. A similar unresolved conundrum exists in many zinc transporters whose measured Km values are in the μm range (59–63). Yet they have to transport zinc in an environment with ∼nm free zinc concentration. For Hh autoprocessing, one possibility is that the local concentration of zinc near plasma membrane is much higher than the measured values. The spatial and temporal distribution of zinc within endoplasmic reticulum is likely to be uneven and dynamic. Hh precursor, bound to the hydrophobic cholesterol is likely to be close to or associated with organelle membrane, where active zinc transport occurs and available zinc is enriched. In addition, HhN also binds zinc (64), further increasing the effective concentration of Zn for the inhibition of Hh autoprocessing. Alternatively, the endoplasmic reticulum environment may decrease Ki dramatically through an unknown mechanism. Lastly, we cannot completely rule out the possibility that zinc inhibits Hh autoprocessing through an indirect signaling effect because of the ubiquitous presence of zinc in many proteins and its signaling roles.
In summary, we have linked Hh signal transduction pathways, important in both development and diseases, with a ubiquitous trace element zinc through the novel discovery that zinc binds directly to the Hint domain and inhibits Hh autoprocessing, as shown both in vitro and in cell culture. Because both zinc and Hh play crucial roles in many aspects of human physiology and diseases, the implication of our finding is profound. When zinc levels are low, Hh autoprocessing may be enhanced, leading to overproduction of Hh ligand and potentially abnormal activation of Hh signaling pathway. This low zinc-high Hh axis may contribute to the pathogenic mechanisms of many types of cancer and ASD (Fig. 6). Our data not only provide novel etiological insights for these diseases but also point to new ways to diagnose and treat diseases by combined measurement and manipulation of zinc level and Hh autoprocessing. Future directions include in-depth investigation of the correlation between zinc level and Hh autoprocessing in selected diseases and further clarification of zinc binding and inhibition mechanism with mutagenesis and structure determination.
This work was supported, in whole or in part, by National Institutes of Health Grant R01GM081408 (NIGMS; to C. W.). This work was also supported in part through Department of Defense Grant W81XWH-14-1-0155 (to B. C.).
- Hh
- Hedgehog
- Hint
- Hedgehog-intein
- ASD
- autism spectrum disorder
- HA
- hydroxylamine
- HSQC
- heteronuclear single quantum correlation
- ITC
- isothermal titration calorimetry
- SMO
- Smoothened
- N-S acyl shift
- nitrogen to sulfur acyl shift.
REFERENCES
- 1. Briscoe J., Thérond P. P. (2013) The mechanisms of Hedgehog signalling and its roles in development and disease. Nat. Rev. Mol. Cell Biol. 14, 416–429 [DOI] [PubMed] [Google Scholar]
- 2. Karhadkar S. S., Bova G. S., Abdallah N., Dhara S., Gardner D., Maitra A., Isaacs J. T., Berman D. M., Beachy P. A. (2004) Hedgehog signalling in prostate regeneration, neoplasia, and metastasis. Nature 431, 707–712 [DOI] [PubMed] [Google Scholar]
- 3. Sanchez P., Hernández A. M., Stecca B., Kahler A. J., DeGueme A. M., Barrett A., Beyna M., Datta M. W., Datta S., Ruiz i Altaba A. (2004) Inhibition of prostate cancer proliferation by interference with Sonic Hedgehog-Gli1 signaling. Proc. Natl. Acad. Sci. U.S.A. 101, 12561–12566 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Sheng T., Li C., Zhang X., Chi S., He N., Chen K., McCormick F., Gatalica Z., Xie J. (2004) Activation of the hedgehog pathway in advanced prostate cancer. Mol. Cancer 3, 29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Watkins D. N., Berman D. M., Burkholder S. G., Wang B., Beachy P. A., Baylin S. B. (2003) Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422, 313–317 [DOI] [PubMed] [Google Scholar]
- 6. Velcheti V., Govindan R. (2007) Hedgehog signaling pathway and lung cancer. J. Thorac. Oncol. 2, 7–10 [DOI] [PubMed] [Google Scholar]
- 7. Chen X., Horiuchi A., Kikuchi N., Osada R., Yoshida J., Shiozawa T., Konishi I. (2007) Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: its inhibition leads to growth suppression and apoptosis. Cancer Sci. 98, 68–76 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Liao X., Siu M. K., Au C. W., Wong E. S., Chan H. Y., Ip P. P., Ngan H. Y., Cheung A. N. (2009) Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion, and differentiation. Carcinogenesis 30, 131–140 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Al-Ayadhi L. Y. (2012) Relationship between Sonic hedgehog protein, brain-derived neurotrophic factor, and oxidative stress in autism spectrum disorders. Neurochem. Res. 37, 394–400 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Pepinsky R. B., Zeng C., Wen D., Rayhorn P., Baker D. P., Williams K. P., Bixler S. A., Ambrose C. M., Garber E. A., Miatkowski K., Taylor F. R., Wang E. A., Galdes A. (1998) Identification of a palmitic acid-modified form of human sonic hedgehog. J. Biol. Chem. 273, 14037–14045 [DOI] [PubMed] [Google Scholar]
- 11. Atwood S. X., Oro A. E. (2014) “Atypical” regulation of hedgehog-dependent cancers. Cancer Cell 25, 133–134 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Zhang L., Zheng Y., Xi Z., Luo Z., Xu X., Wang C., Liu Y. (2009) Metal ions binding to recA inteins from Mycobacterium tuberculosis. Mol. Biosyst. 5, 644–650 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Hall T. M., Porter J. A., Young K. E., Koonin E. V., Beachy P. A., Leahy D. J. (1997) Crystal structure of a Hedgehog autoprocessing domain: homology between Hedgehog and self-splicing proteins. Cell 91, 85–97 [DOI] [PubMed] [Google Scholar]
- 14. Costello L. C., Franklin R. B. (2011) Zinc is decreased in prostate cancer: an established relationship of prostate cancer! J. Biol. Inorg. Chem. 16, 3–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Lakshmi Priya M. D., Geetha A. (2011) Level of trace elements (copper, zinc, magnesium and selenium) and toxic elements (lead and mercury) in the hair and nail of children with autism. Biol. Trace Elem. Res. 142, 148–158 [DOI] [PubMed] [Google Scholar]
- 16. Bjorklund G. (2013) The role of zinc and copper in autism spectrum disorders. Acta Neurobiol. Exp. (Wars) 73, 225–236 [DOI] [PubMed] [Google Scholar]
- 17. Braziewicz J., Bana D., Majewska U., Urbaniak A. (1999) Trace element load in cancer and normal lung tissue. Nucl. Instrum. Methods Phys. Res. B 150, 193–199 [Google Scholar]
- 18. Zhang L., Lv J., Sun S. (2012) Elements in lung tissues of patients from a high lung cancer incidence area of China. Biol. Trace Elem. Res. 148, 7–10 [DOI] [PubMed] [Google Scholar]
- 19. Gumulec J., Masarik M., Adam V., Eckschlager T., Provaznik I., Kizek R. (2014) Serum and tissue zinc in epithelial malignancies: a meta-analysis. PLoS ONE 9, e99790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Blnur N., Drugan A., Brandes M. (1986) Use of the serum copper/zinc malignancy. Clin. Chem. 32, 101–103 [PubMed] [Google Scholar]
- 21. Memon A.-R., Kazi T. G., Afridi H. I., Jamali M. K., Arain M. B., Jalbani N., Syed N. (2007) Evaluation of zinc status in whole blood and scalp hair of female cancer patients. Clin. Chim. Acta 379, 66–70 [DOI] [PubMed] [Google Scholar]
- 22. Xie J., Du Z., Callahan B., Belfort M., Wang C. (2014) 1H, 13C, and 15N NMR assignments of a Drosophila Hedgehog autoprocessing domain. Biomol. NMR Assign. 8, 279–281 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Delaglio F., Grzesiek S., Vuister G. W., Zhu G., Pfeifer J., Bax A. (1995) NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277–293 [DOI] [PubMed] [Google Scholar]
- 24. Zuidema J. M., Hyzinski-García M. C., Van Vlasselaer K., Zaccor N. W., Plopper G. E., Mongin A. A., Gilbert R. J. (2014) Enhanced GLT-1 mediated glutamate uptake and migration of primary astrocytes directed by fibronectin-coated electrospun poly-l-lactic acid fibers. Biomaterials 35, 1439–1449 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Mongin A. A., Hyzinski-García M. C., Vincent M. Y., Keller R. W., Jr. (2011) A simple method for measuring intracellular activities of glutamine synthetase and glutaminase in glial cells. Am. J. Physiol. Cell Physiol. 301, C814–C822 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Chamoun Z., Mann R. K., Nellen D., von Kessler D. P., Bellotto M., Beachy P. A, Basler K. (2001) Skinny hedgehog, an acyltransferase required for palmitoylation and activity of the hedgehog signal. Science 293, 2080–2084 [DOI] [PubMed] [Google Scholar]
- 27. Taipale J., Cooper M. K., Maiti T., Beachy P. A. (2002) Patched acts catalytically to suppress the activity of Smoothened. Nature 418, 892–897 [DOI] [PubMed] [Google Scholar]
- 28. Owen T. S., Xie X. J., Laraway B., Ngoje G., Wang C., Callahan B. P. (2015) Active site targeting of hedgehog precursor protein with phenylarsine oxide. Chembiochem 16, 55–58 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Chen X., Tukachinsky H., Huang C.-H., Jao C., Chu Y.-R., Tang H.-Y., Mueller B., Schulman S., Rapoport T. A, Salic A. (2011) Processing and turnover of the Hedgehog protein in the endoplasmic reticulum. J. Cell Biol. 192, 825–838 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Abràmoff M. D., Hospitals I., Magalhães P. J., Abràmoff M. (2004) Image Processing with ImageJ. Biophotonics International 1–7 [Google Scholar]
- 31. Xia Y.-P., Dai R.-L., Li Y.-N., Mao L., Xue Y.-M., He Q.-W., Huang M., Huang Y., Mei Y.-W., Hu B. (2012) The protective effect of sonic hedgehog is mediated by the phosphoinositide [corrected] 3-kinase/AKT/Bcl-2 pathway in cultured rat astrocytes under oxidative stress. Neuroscience 209, 1–11 [DOI] [PubMed] [Google Scholar]
- 32. Cai C., Thorne J., Grabel L. (2008) Hedgehog serves as a mitogen and survival factor during embryonic stem cell neurogenesis. Stem Cells 26, 1097–1108 [DOI] [PubMed] [Google Scholar]
- 33. Han Y.-G., Spassky N., Romaguera-Ros M., Garcia-Verdugo J.-M., Aguilar A., Schneider-Maunoury S., Alvarez-Buylla A. (2008) Hedgehog signaling and primary cilia are required for the formation of adult neural stem cells. Nat. Neurosci. 11, 277–284 [DOI] [PubMed] [Google Scholar]
- 34. Segawa S., Nishiura T., Furuta T., Ohsato Y., Tani M., Nishida K., Nagasawa K. (2014) Zinc is released by cultured astrocytes as a gliotransmitter under hypoosmotic stress-loaded conditions and regulates microglial activity. Life Sci. 94, 137–144 [DOI] [PubMed] [Google Scholar]
- 35. Bishop G. M., Dringen R., Robinson S. R. (2007) Zinc stimulates the production of toxic reactive oxygen species (ROS) and inhibits glutathione reductase in astrocytes. Free Radic. Biol. Med. 42, 1222–1230 [DOI] [PubMed] [Google Scholar]
- 36. Nolte C., Gore A., Sekler I., Kresse W., Hershfinkel M., Hoffmann A., Kettenmann H., Moran A. (2004) ZnT-1 expression in astroglial cells protects against zinc toxicity and slows the accumulation of intracellular zinc. Glia 48, 145–155 [DOI] [PubMed] [Google Scholar]
- 37. Maret W. (2012) New perspectives of zinc coordination environments in proteins. J. Inorg. Biochem. 111, 110–116 [DOI] [PubMed] [Google Scholar]
- 38. Szewczyk B. (2013) Zinc homeostasis and neurodegenerative disorders. Front. Aging Neurosci. 5, 33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Yamasaki S., Sakata-Sogawa K., Hasegawa A., Suzuki T., Kabu K., Sato E., Kurosaki T., Yamashita S., Tokunaga M., Nishida K., Hirano T. (2007) Zinc is a novel intracellular second messenger. J. Cell Biol. 177, 637–645 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Kolenko V., Teper E., Kutikov A., Uzzo R. (2013) Zinc and zinc transporters in prostate carcinogenesis. Nat. Rev. Urol. 10, 219–226 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Carvalho M. L., Magalhães T., Becker M., von Bohlen A. (2007) Trace elements in human cancerous and healthy tissues: a comparative study by EDXRF, TXRF, synchrotron radiation, and PIXE. Spectrochim. Acta Part B. At. Spectrosc. 62, 1004–1011 [Google Scholar]
- 42. Yauch R. L., Dijkgraaf G. J., Alicke B., Januario T., Ahn C. P., Holcomb T., Pujara K., Stinson J., Callahan C. A., Tang T., Bazan J. F., Kan Z., Seshagiri S., Hann C. L., Gould S. E., Low J. A., Rudin C. M., de Sauvage F. J. (2009) Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326, 572–574 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Blumberg S. J., Bramlett M. D. (2013) Changes in Prevalence of Parent-reported Autism Spectrum Disorder in School-aged U. S. Children: 2007 to 2011–2012. National Health Statistics Reports 65, 1–12 [PubMed] [Google Scholar]
- 44. McGinnis W. R. (2005) Oxidative stress in autism. Altern. Ther. Health Med. 11, 19. [PubMed] [Google Scholar]
- 45. Grabrucker A. M. (2012) Environmental factors in autism. Front. Psychiatry 3, 118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Redcay E., Courchesne E. (2005) When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol. Psychiatry 58, 1–9 [DOI] [PubMed] [Google Scholar]
- 47. Elder L. M., Dawson G., Toth K., Fein D., Munson J. (2008) Head circumference as an early predictor of autism symptoms in younger siblings of children with autism spectrum disorder. J. Autism Dev. Disord. 38, 1104–1111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. White S., O'Reilly H., Frith U. (2009) Big heads, small details, and autism. Neuropsychologia 47, 1274–1281 [DOI] [PubMed] [Google Scholar]
- 49. Lien W.-H., Klezovitch O., Fernandez T. E., Delrow J., Vasioukhin V. (2006) alphaE-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway. Science 311, 1609–1612 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Britto J., Tannahill D., Keynes R. (2002) A critical role for sonic hedgehog signaling in the early expansion of the developing brain. Nat. Neurosci. 5, 103–110 [DOI] [PubMed] [Google Scholar]
- 51. Nanni L., Ming J. E., Bocian M., Steinhaus K., Bianchi D. W., Die-Smulders C., Giannotti A., Imaizumi K., Jones K. L., Campo M. D., Martin R. A., Meinecke P., Pierpont M. E., Robin N. H., Young I. D., Roessler E., Muenke M. (1999) The mutational spectrum of the sonic hedgehog gene in holoprosencephaly: SHH mutations cause a significant proportion of autosomal dominant holoprosencephaly. Hum. Mol. Genet. 8, 2479–2488 [DOI] [PubMed] [Google Scholar]
- 52. Belloni E., Muenke M., Roessler E., Traverso G., Siegel-Bartelt J., Frumkin A., Mitchell H. F., Donis-Keller H., Helms C., Hing A. V., Heng H. H., Koop B., Martindale D., Rommens J. M., Tsui L. C., Scherer S. W. (1996) Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat. Genet. 14, 353–356 [DOI] [PubMed] [Google Scholar]
- 53. Roessler E., Belloni E., Gaudenz K., Vargas F., Scherer S. W., Tsui L. C., Muenke M. (1997) Mutations in the C-terminal domain of Sonic Hedgehog cause holoprosencephaly. Hum. Mol. Genet. 6, 1847–1853 [DOI] [PubMed] [Google Scholar]
- 54. Maity T., Fuse N., Beachy P. A. (2005) Molecular mechanisms of Sonic hedgehog mutant effects in holoprosencephaly. Proc. Natl. Acad. Sci. U.S.A. 102, 17026–17031 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Vinkenborg J. L., Nicolson T. J., Bellomo E. A., Koay M. S., Rutter G. A., Merkx M. (2009) Genetically encoded FRET sensors to monitor intracellular Zn2+ homeostasis. Nat. Methods 6, 737–740 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Chabosseau P., Tuncay E., Meur G., Bellomo E. A., Hessels A., Hughes S., Johnson P. R., Bugliani M., Marchetti P., Turan B., Lyon A. R., Merkx M., Rutter G. A. (2014) Mitochondrial and ER-Targeted eCALWY Probes Reveal High Levels of Free Zn2+. ACS Chem. Biol. 9, 2111–2120 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Hessels A. M., Merkx M. (2015) Genetically-encoded FRET-based sensors for monitoring Zn2+ in living cells. Metallomics 7, 258–266 [DOI] [PubMed] [Google Scholar]
- 58. Bellomo E. A., Meur G., Rutter G. A. (2011) Glucose regulates free cytosolic Zn2+ concentration, Slc39 (ZiP), and metallothionein gene expression in primary pancreatic islet β-cells. J. Biol. Chem. 286, 25778–25789 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Gaither L. A., Eide D. J. (2001) The human ZIP1 transporter mediates zinc uptake in human K562 erythroleukemia cells. J. Biol. Chem. 276, 22258–22264 [DOI] [PubMed] [Google Scholar]
- 60. Dufner-Beattie J., Wang F., Kuo Y.-M., Gitschier J., Eide D., Andrews G. K. (2003) The acrodermatitis enteropathica gene ZIP4 encodes a tissue-specific, zinc-regulated zinc transporter in mice. J. Biol. Chem. 278, 33474–33481 [DOI] [PubMed] [Google Scholar]
- 61. Gaither L. A. (2000) Functional expression of the human hZIP2 zinc transporter. J. Biol. Chem. 275, 5560–5564 [DOI] [PubMed] [Google Scholar]
- 62. Eide D. J. (2006) Zinc transporters and the cellular trafficking of zinc. Biochim. Biophys. Acta 1763, 711–722 [DOI] [PubMed] [Google Scholar]
- 63. Dufner-Beattie J., Langmade S. J., Wang F., Eide D., Andrews G. K. (2003) Structure, function, and regulation of a subfamily of mouse zinc transporter genes. J. Biol. Chem. 278, 50142–50150 [DOI] [PubMed] [Google Scholar]
- 64. Hall T. M., Porter J. A., Beachy P. A., Leahy D. J. (1995) A potential catalytic site revealed by the 1.7-Å crystal structure of the amino-terminal signalling domain of sonic hedgehog. Nature 378, 212–216 [DOI] [PubMed] [Google Scholar]